Characterization of Konjac Ceramide (kCer) Binding to Sema3A Receptor Nrpl

被引:4
|
作者
Usuki, Seigo [1 ]
Tamura, Noriko [2 ]
Tamura, Tomohiro [2 ]
Mukai, Katsuyuki [3 ]
Igarashi, Yasuyuki [1 ]
机构
[1] Hokkaido Univ, Fac Adv Life Sci, Lipid Biofunct Sect, Frontier Res Ctr Adv Mat & Life Sci, Sapporo, Hokkaido, Japan
[2] Natl Inst Adv Ind Sci & Technol, Sapporo, Hokkaido, Japan
[3] Daicel Corp, R&D Headquarters, Tokyo, Japan
关键词
ceramide; konjac; NGF; semaphorin; 3A; neurite outgrowth; CRMP2; SEMAPHORIN-3A; EXPRESSION; ITCH;
D O I
10.5650/jos.ess17142
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Konjac ceramide (kCer) can be prepared by a chemoenzymatic method as previously published (Usuki, S.; Tamura, N.; Sakai, S.; Tamura, T.; Mukai, K.; Igarashi, Y. Biochem. Biophys. Rep. 5, 160-167 (2016)). Thus prepared kCer showed an activation effect on Sema3A signaling pathway to induce phosphorylation of CRMP2 and microtubule depolymerizaion, resulting in opposing NGF-induced neurite outgrowth. In the present study, we have shown that kCer is a potential Sema3A-like ligand that has a competitive effect on Sema3A binding to a cell surface receptor Nrpl, but animal-type ceramides have no effect on Sema3A binding to Nrpl. In addition, kCer showed a direct molecular interaction with Nrpl, but animal-type ceramides, Cl6Cer, Cl8Cer, and C24Cer show no specific bindings to Nrpl. Further, kCer showed an additive effect to activate the Sema3A signaling pathway together with low-dose Sema3A but a reversed effect to inhibit this pathway when combined with high-dose Sema3A.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 50 条
  • [21] CHARACTERIZATION OF THE RECEPTOR-BINDING PROFILE OF (H-3) DERMORPHIN IN THE RAT-BRAIN
    AMICHE, M
    SAGAN, S
    MOR, A
    DELFOUR, A
    NICOLAS, P
    INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1988, 32 (06): : 506 - 511
  • [22] Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A
    Yao, YN
    Mayer, ML
    JOURNAL OF NEUROSCIENCE, 2006, 26 (17): : 4559 - 4566
  • [23] MECHANISM OF THE OVARY IN THYROIDECTOMIZED RATS .3. CHARACTERIZATION OF THE GONADOTROPIN RECEPTOR-BINDING INHIBITORS
    HAYASHI, K
    FUJII, T
    FOLIA PHARMACOLOGICA JAPONICA, 1983, 82 (06) : P169 - P170
  • [24] IDENTIFICATION AND CHARACTERIZATION OF 3 CALMODULIN-BINDING SITES OF THE SKELETAL-MUSCLE RYANODINE RECEPTOR
    MENEGAZZI, P
    LARINI, F
    TREVES, S
    GUERRINI, R
    QUADRONI, M
    ZORZATO, F
    BIOCHEMISTRY, 1994, 33 (31) : 9078 - 9084
  • [25] ISOLATION AND CHARACTERIZATION AS A GLYCOPROTEIN OF THE C3B-BINDING ENTITY OF HUMAN C3B-RECEPTOR
    MUSSEL, HH
    EHLEN, T
    SCHMITT, M
    NEYSES, L
    SCHEINER, O
    DIERICH, MP
    IMMUNOBIOLOGY, 1981, 159 (1-2) : 120 - 121
  • [26] CHARACTERIZATION OF HEPARIN-BINDING GROWTH-ASSOCIATED FACTOR RECEPTOR ON NIH 3T3 CELLS
    KUO, MD
    HUANG, SS
    HUANG, JS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (01) : 188 - 194
  • [27] Overexpression of relaxin family peptide receptor 3 in Escherichia coli and characterization of its ligand binding properties
    Hu, Meng-Jun
    Wang, Jia-Hui
    Shao, Xiao-Xia
    Xu, Zeng-Guang
    Guo, Zhan-Yun
    PROCESS BIOCHEMISTRY, 2018, 69 : 131 - 135
  • [28] Structural Characterization of Agonist Binding to an A3 Adenosine Receptor through Biomolecular Simulations and Mutagenesis Experiments
    Stamatis, Dimitrios
    Lagarias, Panagiotis
    Barkan, Kerry
    Vrontaki, Eleni
    Ladds, Graham
    Kolocouris, Antonios
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (19) : 8831 - 8846
  • [29] Pharmacological characterization and identification of EP3 prostanoid receptor binding sites in hamster uterus homogenates
    Sharif, NA
    Xu, SX
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (02) : 197 - 203
  • [30] Binding characterization of [3H]S-0139, an antagonist of the endothelin ETA receptor subtype
    Mihara, S
    Tozawa, F
    Itazaki, K
    Fujimoto, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (2-3) : 319 - 324